Hongchi Jiang
Impact in
- Cancer Research top 0.5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
-
- Cancer, Hypoxia, and Metabolism 26
- MicroRNA in disease regulation 13
- Hepatology 24
Hongchi Jiang
203 papers receiving 6.7k citations
Peers
Comparison fields: 5 of 140
- Cancer Research 1.8k
- Hepatology 652
- Molecular Biology 3.5k
- Biochemistry 350
- Oncology 1.3k
Countries citing papers authored by Hongchi Jiang
This map shows the geographic impact of Hongchi Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongchi Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongchi Jiang more than expected).
Fields of papers citing papers by Hongchi Jiang
This network shows the impact of papers produced by Hongchi Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongchi Jiang. The network helps show where Hongchi Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongchi Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 10 | |
| 3 | 2023 | 9 | |
| 4 | 2022 | 28 | |
| 5 | 2021 | 17 | |
| 6 | 2021 | 43 | |
| 7 | 2020 | 26 | |
| 8 | 2019 | 6 | |
| 9 | 2019 | 5 | |
| 10 | 2019 | 16 | |
| 11 | 2019 | 162 | |
| 12 | 2018 | 8 | |
| 13 | 2014 | 245 | |
| 14 | 2013 | 77 | |
| 15 | 2011 | 54 | |
| 16 | 2010 | 1 | |
| 17 | [Protection of CSE/H2S system in hepatic ischemia reperfusion injury in rats]. | 2010 | 7 |
| 18 | 2010 | 1 | |
| 19 | Down-regulation of lung resistance related protein by RNA interference targeting survivin induces the reversal of chemoresistances in hepatocellular carcinoma. | 2009 | 10 |
| 20 | 2009 | 72 |
About Hongchi Jiang
Hongchi Jiang is a scholar working on Cancer Research, Hepatology, Oncology, Molecular Biology and Pathology and Forensic Medicine, having authored 210 papers that have together received 6.8k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (26 papers), Cancer Mechanisms and Therapy (16 papers), RNA modifications and cancer (14 papers), Retinoids in leukemia and cellular processes (14 papers), Cancer-related Molecular Pathways (13 papers), MicroRNA in disease regulation (13 papers), Angiogenesis and VEGF in Cancer (13 papers) and Pancreatitis Pathology and Treatment (12 papers). The work is most often cited by research in Cancer Research (1.8k citations), Hepatology (652 citations), Molecular Biology (3.5k citations), Biochemistry (350 citations) and Oncology (1.3k citations). Hongchi Jiang has collaborated with scholars based in China, New Zealand and United States. Frequent co-authors include Xueying Sun, Shangha Pan, Haiquan Qiao, Xian Jiang, Bei Sun, Xuesong Dong, Bo Zhai, Lianxin Liu, Jiabei Wang and Tongsen Zheng. Their work appears in journals such as Cancer Science, PLoS ONE, Cancer Letters, Journal of Surgical Research and Tumor Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.